These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1763136)

  • 1. The potential use of catalytic RNAs in therapy of HIV infection and other diseases.
    Rossi JJ; Cantin EM; Sarver N; Chang PF
    Pharmacol Ther; 1991; 50(2):245-54. PubMed ID: 1763136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA enzymes (ribozymes) as antiviral therapeutic agents.
    Rossi JJ; Sarver N
    Trends Biotechnol; 1990 Jul; 8(7):179-83. PubMed ID: 1366622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of catalytic antisense RNAs (ribozymes).
    Rossi JJ
    Ciba Found Symp; 1997; 209():195-204; discussion 204-6. PubMed ID: 9383577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and Ribozymes.
    Scarborough RJ; Gatignol A
    Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.
    Rossi JJ; Elkins D; Zaia JA; Sullivan S
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):183-9. PubMed ID: 1540406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.
    Rossi JJ; Sarver N
    Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448
    [No Abstract]   [Full Text] [Related]  

  • 9. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ribozymes for gene therapy.
    Sullivan SM
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):85S-89S. PubMed ID: 7963690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral and anticancer ribozymes.
    Poeschla E; Wong-Staal F
    Curr Opin Oncol; 1994 Nov; 6(6):601-6. PubMed ID: 7827172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.
    Smythe JA; Symonds G
    Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress toward the structure and therapeutic use of the hairpin ribozyme.
    Earnshaw DJ; Gait MJ
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):403-11. PubMed ID: 9303192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of ribozymes.
    Kijima H; Ishida H; Ohkawa T; Kashani-Sabet M; Scanlon KJ
    Pharmacol Ther; 1995; 68(2):247-67. PubMed ID: 8719970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?
    Akhtar S; Rossi JJ
    J Antimicrob Chemother; 1996 Aug; 38(2):159-65. PubMed ID: 8877530
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication and dimerization interference by dual inhibitory RNAs.
    Sánchez-Luque FJ; Reyes-Darias JA; Puerta-Fernández E; Berzal-Herranz A
    Molecules; 2010 Jul; 15(7):4757-72. PubMed ID: 20657391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology evaluation: HIV ribozyme gene therapy, Gene Shears Pty Ltd.
    de Feyter R; Li P
    Curr Opin Mol Ther; 2000 Jun; 2(3):332-5. PubMed ID: 11249628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozymes as therapies for AIDS.
    Rossi JJ; Cantin EM; Zaia JA; Ladne PA; Chen J; Stephens DA; Sarver N; Chang PS
    Ann N Y Acad Sci; 1990; 616():184-200. PubMed ID: 2078019
    [No Abstract]   [Full Text] [Related]  

  • 20. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.